甲状腺癌诊断市场Share, Size, Trends, Industry Analysis Report, By Type (Papillary Carcinoma, Follicular Carcinoma); By Technique (Blood Test, Imaging, Biopsy); By End-Use (Hospital Laboratories, Cancer Diagnostics Centers, Research Institutes); By Regions; Segment Forecast, 2021 - 2028

Report Summary

The global thyroid cancer diagnostics market was valued at USD 2.50 billion in 2020 and is expected to grow at a CAGR of 5.7% during the forecast period. The increasing prevalence of thyroid cancer with a strong focus on early diagnosis coupled with an aging population across the globe are the prominent factors responsible for the market growth.

Thyroid cancer is a common form of malignant endocrine glands. Papillary and follicular cancers comprise up to 90 percent of thyroid cancer. It is being estimated that the prevalence rate of thyroid cancer is 4.5 percent in females and 2 percent in males. The condition is more prevalent in Caucasian women aged between 20-34 years. Moreover, rising government initiatives and an increase in funding towards early diagnosis of the condition also favoring the concerned diagnostics market growth.

Know more about this report:请求样本页面

行业动态

增长司机
Most of the associations and academic institutions are involved in research and development to develop new products and services for better treatment, diagnosis, and prevention of thyroid cancer. For instance, American Thyroid Organization and Thyroid Cancer Survivor Association are involved in activities such as a deeper understanding of molecular mechanisms, identifying key genes for targeted diagnosis and treatment methods. In 2018, National Cancer Institute’s (NCI), My Pediatric and Adult Rare Tumor network has established a rare tumor facility for people suffering from medullary thyroid cancer, who have not received standard treatment.

研究人员使用这些组织样本来了解它背后的遗传，以创造有效的治疗手册。此外，在同一年，FDA批准了在涉及两种药物Dabrafenib甲磺酸盐和曲滴虫的市场中的组合治疗，用于治疗一个突变甲状腺癌，在BRAF基因中突变。据估计，超过四分之一的气相生甲状腺癌具有这种突变。

甲状腺癌诊断市场报告范围

The market is primarily segmented on the basis of type, technique, end-use, and region.

按类型	通过技术	By End-Use	By Region
Papillary Carcinoma Follicular Carcinoma 其他	验血 Imaging Biopsy 其他	医院实验室 癌症诊断中心 Research Institutes 其他	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太（日本，中国，印度，马来西亚，印度尼西亚，韩国） 拉丁美洲(巴西、墨西哥、基于“增大化现实”技术gentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:请求样本页面

界面类型

Based on the type, the global thyroid cancer diagnostics market is categorized into papillary, follicular carcinoma, and others. In 2020, the papillary carcinoma segment accounted for the largest market revenue share. The concerned condition had the highest cure rate among all the cancers, with a 5-year survival rate of nearly 98 percent.

预计卵泡癌对评估期间有利于利润丰厚的市场增长。这些是最常见的形式，包括突然的，髓质，呼吸癌。卵泡癌在早期阶段转移到几个淋巴结的预后率最差，从而需要复杂的手术。

技术洞察力

Based on the technique, the global thyroid cancer diagnostics market is bifurcated into blood tests, imaging, biopsy, and others. In 2020, the imaging segment accounted for the largest share. Such a high share is due to the fact that imaging tests are the primary requirements for disease diagnosis. Thyroid ultrasounds evaluate structural anomalies, while blood tests measure Thyroxine, T3, and T4 levels to examine functional differences.

此外，通过遗传预后和分子试验促进了甲状腺癌中的诊断市场景观。颈部超声是癌症诊断最常见的工具。其他成像测试包括胸部X射线，PET扫描和骨扫描以识别转移。此外，关于诊断技术投资和高程序成本也有助于分部的增长。

最终用途的洞察

基于最终用途，全球市场分叉进入医院实验室，癌症诊断中心，研究机构等。2020年，医院实验室分部占最大的份额。有关诊断市场增长归因于患有甲状腺癌的患者，患者对早期诊断的患者意识，以及医疗保健基础设施的投资上升。乐动娱乐官网

但是，研究机构的市场部门预计将在评估期内见证最高增长率。这是由于对癌症研究的研究资金上升，例如，美国甲状腺协会（ATA）资助了105多个研究赠款，价值约280万美元。

地理概述

Geographically, the global diagnostics market is bifurcated into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is the largest revenue contributor followed by Europe and the Asia Pacific region. In 2020, the North America region accounted for over 42 percent of the global market.

负责诊断市场增长的区域因素包括强有力的行业 - 学术界合作，合适的研究基础设施存在，关键公司的存在，以及能够负担这种高成本药物的人的高可支配收入。

Asia Pacific is projected to witness the highest growth in the concerned diagnostics market over the assessment period. High prevalence of thyroid cancer, improving healthcare infrastructure in both India and China, and patient’s awareness regarding its ill effects.

Competitive Insight

在市场上运营的着名球员是Abbott，Roche Ltd，Thermo Fisher Scientific，Siemens Healthcare，Bio-Rad Laboratories，General电气乐动娱乐官网，Koninklijke Philips，Toshiba Corporation，Agilent Technologies和Illumina，Inc。